Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study

People who inject drugs (PWID) experience high incarceration rates which are associated with increased hepatitis C virus (HCV) transmission risk. We assess the importance of prison‐based interventions for achieving HCV elimination among PWID in New South Wales (NSW), Australia.

• Publication year

  2022

• Venue

  Liver international (Print)

• Publication date

  2022-10-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/liv.15469PMID 36305315PMCID 10308445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study

  2022cited by this paper
• Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.

  2021cited by this paper
• Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky

  2020cited by this paper
• Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.

  2020cited by this paper
• Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.

  2020cited by this paper
• Australia needs to increase testing to achieve hepatitis C elimination

  2020cited by this paper
• Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.

  2019cited by this paper
• The Global State of Harm Reduction in Prisons

  2019cited by this paper
• The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.

  2019cited by this paper
• Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

  2019cited by this paper
• Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis.

  2018cited by this paper
• Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

  2018cited by this paper
• Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

  2018cited by this paper
• Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study

  2017cited by this paper
• Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland

  2017cited by this paper
• Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

  2017cited by this paper
• Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

  2017cited by this paper
• Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

  2017cited by this paper
• Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.

  2017cited by this paper
• Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

  2017cited by this paper
• Public health and international drug policy.

  2016cited by this paper
• Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model

  2016cited by this paper
• Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors.

  2015cited by this paper
• The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service

  2015cited by this paper
• Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS‐c study

  2014cited by this paper
• Imprisonment of opioid‐dependent people in New South Wales, Australia, 2000–2012: a retrospective linkage study

  2014cited by this paper
• The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.

  2014cited by this paper
• Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

  2013cited by this paper
• The effectiveness of opioid maintenance treatment in prison settings: a systematic review.

  2012cited by this paper
• Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.

  2012cited by this paper
• Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.

  2009cited by this paper
• Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.

  2009cited by this paper
• Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

  2006cited by this paper
• Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.

  2006cited by this paper
• Addressing prisoner drug use : prevalence, nature and context : 3rd collection of a biennial survey of prisoners in New South Wales

  2005cited by this paper

• The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated: a multistage systematic review.

  2026cites this paper
• Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings: A systematic review.

  2026cites this paper
• Using the socioecological model to guide service delivery improvements to the prison needle exchange program in Canada: insights from multi-level stakeholders

  2025cites this paper
• Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study

  2025cites this paper
• Changes in hepatitis C virus infections after implementation of an expanded treatment program in New Mexico state prisons.

  2025cites this paper
• Identifying barriers and facilitators to accessing harm reduction services in prisons: A systematic narrative synthesis.

  2025cites this paper
• Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling study

  2024cites this paper
• Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?

  2024cites this paper
• Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.

  2024cites this paper
• Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis

  2024cites this paper
• Cost–benefit analysis of Canada’s Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections

  2024cites this paper
• Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination

  2023cites this paper
• Incidence of hepatitis C virus infection in the prison setting: The SToP‐C study

  2023cites this paper
• The path to hepatitis C elimination: who are we leaving behind and why?

  2023cites this paper
• Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study

  2022cites this paper